Silicon Infusion's HDRM-D2 Demodulator gets 256QAM Option
October 6, 2011 -- The Zaltys High Performance Enhanced Demodulator (HDRM-D2) now has the capability of demodulating 256QAM, further increasing the data rate that can be handled by this versatile core. When used with Xilinx Virtex-6 technology, the core is capable of operation at clock rates in excess of 250MHz, resulting in a maximum symbol rate of 100MS/s, which in combination with 256QAM operation leads to a maximum bit rate of 800Mb/s.
The high resolution data path and integrated adaptive equaliser features of the HDRM-D2 core make it ideally suited to recover high-order modualtion schemes such as 256QAM.
256QAM is an optional addition to the functionality of the HDRM-D2 core, and should be requested at time of order.
|
Silicon Infusion Ltd. Hot IP
Related News
- Silicon Infusion Announces 3-Layer ISDB-T Demodulator
- SIDSA launches the World's first demodulator plus application processor Silicon for Portable and Mobile TV
- Silicon Hive, a semiconductor IP supplier in the Philips Technology Incubator, Demonstrates World's First Fully Programmable Digital TV Demodulator IP Core
- GUC Announces Successful Launch of Industry's First 32G UCIe Silicon on TSMC 3nm and CoWoS Technology
- Marvell Demonstrates Industry's Leading 2nm Silicon for Accelerated Infrastructure
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |